These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1672775)

  • 1. Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.
    Wijnands MJ; Nuver-Zwart IH; van Riel PL; van 't Hof MA; Gribnau FW; van De Putte LB
    Scand J Rheumatol; 1991; 20(1):52-7. PubMed ID: 1672775
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of sulphasalazine use in rheumatoid arthritis.
    McConkey B
    Br J Rheumatol; 1989 Apr; 28(2):175-6. PubMed ID: 2565130
    [No Abstract]   [Full Text] [Related]  

  • 4. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
    Chalmers IM; Sitar DS; Hunter T
    J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic anemia in patients receiving sulfasalazine.
    Goodacre RL; Ali MA; Vanderlinden B; Hamilton JD; Castelli M; Seaton T
    Digestion; 1978; 17(6):503-8. PubMed ID: 30666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal agranulocytosis with sulfasalazine therapy in rheumatoid arthritis.
    Canvin JM; el-Gabalawy HS; Chalmers IM
    J Rheumatol; 1993 May; 20(5):909-10. PubMed ID: 8101571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.
    Narayan N; Rigby S; Carlucci F
    Clin Rheumatol; 2017 Feb; 36(2):477-479. PubMed ID: 27778097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.
    Guillemin F; Aussedat R; Guerci A; Lederlin P; Trechot P; Pourel J
    J Rheumatol; 1989 Aug; 16(8):1166-7. PubMed ID: 2573730
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfasalazine induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Siam AR; Hammoudeh M
    J Rheumatol; 1993 Jan; 20(1):207. PubMed ID: 8095074
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.
    Williams HJ; Ward JR; Dahl SL; Clegg DO; Willkens RF; Oglesby T; Weisman MH; Schlegel S; Michaels RM; Luggen ME
    Arthritis Rheum; 1988 Jun; 31(6):702-13. PubMed ID: 2898244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticuloendothelial system function in rheumatoid arthritis.
    Brandslund I; Petersen PH
    Lancet; 1979 Sep; 2(8143):633. PubMed ID: 90291
    [No Abstract]   [Full Text] [Related]  

  • 15. Salazopyrin in rheumatoid arthritis.
    McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
    Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.
    Crilly A; Capell HA; Watson J; Madhok R
    Clin Rheumatol; 1995 Sep; 14(5):561-5. PubMed ID: 8549096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sulfasalazine in rheumatoid arthritis].
    Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
    Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 19. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
    Winkler V
    Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.